Sign in Sign up for free

Theratechnologies Quick ratio

What is the Quick ratio of Theratechnologies?

The Quick ratio of Theratechnologies, Inc. is 1.00

What is the definition of Quick ratio?



Quick ratio is liquidity ratio that measures a company’s ability to use its quick assets to meet its short-term obligations immediately.

mrq (most recent quarter)

The quick ratio is the ratio between quick or liquid assets and current liabilities. Quick assets include those current assets that presumably can be quickly converted to cash at close to their book values. A normal liquid ratio is considered to be 1. A company with a quick ratio of less than 1 cannot at the time fully pay its current liabilities or short-term obligations. This ratio is considered to be a much reliable tool for assessment of liquidity position of companies.

Quick ratio of companies in the Health Care sector on TSX compared to Theratechnologies

What does Theratechnologies do?

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.

Companies with quick ratio similar to Theratechnologies